|
RAB23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.351410E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.206000E-01 |
| Normal-vs-Stage2 |
2.349600E-01 |
| Normal-vs-Stage3 |
3.691700E-02 |
| Normal-vs-Stage4 |
1.342980E-01 |
| Stage1-vs-Stage2 |
1.773450E-01 |
| Stage1-vs-Stage3 |
2.066200E-02 |
| Stage1-vs-Stage4 |
1.199230E-01 |
| Stage2-vs-Stage3 |
3.737000E-01 |
| Stage2-vs-Stage4 |
2.744600E-01 |
| Stage3-vs-Stage4 |
5.099200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.395200E-01 |
| Normal-vs-AfricanAmerican |
9.971900E-02 |
| Normal-vs-Asian |
1.402750E-01 |
| Caucasian-vs-AfricanAmerican |
4.913000E-01 |
| Caucasian-vs-Asian |
5.882600E-01 |
| AfricanAmerican-vs-Asian |
7.237200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.158400E-01 |
| Normal-vs-Female |
1.750290E-02 |
| Male-vs-Female |
3.189600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.357600E-01 |
| Normal-vs-Extreme_Weight |
9.104200E-01 |
| Normal-vs-Obese |
8.155600E-02 |
| Normal-vs-Extreme_Obese |
8.695400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.613200E-01 |
| Normal_Weight-vs-Obese |
1.396380E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.493400E-01 |
| Extreme_Weight-vs-Obese |
6.873900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.551400E-01 |
| Obese-vs-Extreme_Obese |
2.800000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.618400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.976500E-03 |
| Normal-vs-Age(61-80Yrs) |
6.525000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.030800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.977000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.394550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.071900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.386120E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.986200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.222200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.027050E-01 |
| Normal-VS-Type2 PRCC |
8.382800E-01 |
| Normal-VS-KIRP CIMP |
1.233380E-01 |
| Normal-VS-Unclassified PRCC |
2.198400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.038200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.649420E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.310000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.182570E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.819370E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.849770E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.286600E-01 |
| Normal-vs-N1 |
1.185900E-02 |
| Normal-vs-N2 |
4.966100E-02 |
| N0-vs-N1 |
1.585870E-02 |
| N0-vs-N2 |
2.621000E-01 |
| N1-vs-N2 |
1.295820E-01 |
|
|
